{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:23:37Z","timestamp":1787847817507,"version":"build-2784847793"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Due to high morbidity and mortality rates, colorectal cancer (CRC) poses the significant global health challenge, thus early screening is essential to improve patient outcomes. DNA methylation biomarkers have become pivotal tools for detection of CRC, moving from research to clinical use. Key methylation loci (SEPT9, BMP3, and NDRG4) have been identified through genome-wide association studies and candidate gene approaches, then validated with high-throughput technologies, such as methylation arrays and next-generation sequencing. This advancement has led to the creation of clinically approved assays. Notably, the sensitivity of the Cologuard assay for detection of CRC is 92%, while that of the Epi proColon assay is 70%\u201380%, both outperforming traditional methods like fecal immunochemical testing, which has a sensitivity of 74%. These assays offer non-invasive screening for both average- and high-risk groups, and aid in postoperative monitoring. However, significant challenges remain. Key issues include technical difficulties for detection of low-abundance methylation signals and standardization of sample processing methods. Clinically, managing false results and validating long-term efficacy are problematic. Ethical concerns about overdiagnosis and data privacy also require attention. Future efforts should prioritize technological advancements, like single-molecule sequencing and liquid biopsy integration, along with large-scale prospective studies to validate biomarker utility in diverse populations. Updated guidelines for standardized implementation are also crucial. This review underscores the pivotal role of methylation biomarkers to revolutionize screening of CRC, while stressing the need for interdisciplinary collaboration, and outlines a strategy to address current limitations, ultimately aiming to reduce the global impact of CRC.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_938_25","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:00:20Z","timestamp":1779951620000},"page":"231-240","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Methylation biomarkers for early detection of colorectal cancer: From molecular discovery to clinical translation and application"],"prefix":"10.4103","volume":"22","author":[{"given":"Yangfeng","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Qingyang District, Chengdu, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Anesthesia Surgery Center, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Qingyang District, Chengdu, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Qingyang District, Chengdu, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20260528","first-page":"209","article-title":"Global cancer statistics in 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20260528","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.4103\/jcrt.jcrt_933_24","article-title":"Research progress on the structural and anti-colorectal malignant tumor properties of Shikonin","volume":"20","author":"Chen","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R3-20260528","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: Profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J (Peking)"},{"key":"R4-20260528","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canep.2018.09.003","article-title":"Three years of colorectal cancer screening in Denmark","volume":"57","author":"Njor","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"R5-20260528","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1136\/gutjnl-2014-309086","article-title":"Colorectal cancer screening: A global overview of existing programmes","volume":"64","author":"Schreuders","year":"2015","journal-title":"Gut"},{"key":"R6-20260528","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archinternmed.2012.332","article-title":"Adherence to colorectal cancer screening: A randomized clinical trial of competing strategies","volume":"172","author":"Inadomi","year":"2012","journal-title":"Arch Intern Med"},{"key":"R7-20260528","first-page":"408","article-title":"Colonoscopic polypectomy and long-term prevention of colorectal cancer deaths","volume":"212","author":"S\u00e1nchez","year":"2012","journal-title":"Rev Clin Esp"},{"key":"R8-20260528","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5009\/gnl.2014.8.2.117","article-title":"Population screening for colorectal cancer means getting FIT: The past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT)","volume":"8","author":"Allison","year":"2014","journal-title":"Gut Liver"},{"key":"R9-20260528","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.11101887","article-title":"Colorectal cancer: CT colonography and colonoscopy for detection-systematic review and meta-analysis","volume":"259","author":"Pickhardt","year":"2011","journal-title":"Radiology"},{"key":"R10-20260528","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1038\/s41467-024-51424-4","article-title":"multi-omic lineage tracing predicts the transcriptional, epigenetic and genetic determinants of cancer evolution","volume":"15","author":"Nadalin","year":"2024","journal-title":"Nat Commun"},{"key":"R11-20260528","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"},{"key":"R12-20260528","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat Med"},{"key":"R13-20260528","doi-asserted-by":"crossref","first-page":"eaax7533","DOI":"10.1126\/scitranslmed.aax7533","article-title":"Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer","volume":"12","author":"Luo","year":"2020","journal-title":"Sci Transl Med"},{"key":"R14-20260528","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"R15-20260528","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10620-014-3451-5","article-title":"Multi-target stool DNA test: A new high bar for noninvasive screening","volume":"60","author":"Ahlquist","year":"2015","journal-title":"Dig Dis Sci"},{"key":"R16-20260528","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0168-9525(97)01268-7","article-title":"How does DNA methylation repress transcription?","volume":"13","author":"Kass","year":"1997","journal-title":"Trends Genet"},{"key":"R17-20260528","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"key":"R18-20260528","doi-asserted-by":"crossref","first-page":"629390","DOI":"10.3389\/fonc.2021.629390","article-title":"Advances in CpG Island methylator phenotype colorectal cancer therapies","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"R19-20260528","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/SLA.0000000000002901","article-title":"Circulating free methylated tumor DNA markers for sensitive assessment of tumor burden and early response monitoring in patients receiving systemic chemotherapy for colorectal cancer liver metastasis","volume":"268","author":"Bhangu","year":"2018","journal-title":"Ann Surg"},{"key":"R20-20260528","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/codi.13336","article-title":"Hypermethylated DNA as a biomarker for colorectal cancer: A systematic review","volume":"18","author":"Rasmussen","year":"2016","journal-title":"Colorectal Dis"},{"key":"R21-20260528","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5217\/ir.2017.15.4.495","article-title":"Is methylation analysis of SFRP2, TFPI2, NDRG4, and BMP3 promoters suitable for colorectal cancer screening in the Korean population?","volume":"15","author":"Park","year":"2017","journal-title":"Intest Res"},{"key":"R22-20260528","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4161\/epi.27644","article-title":"DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia","volume":"9","author":"Ashktorab","year":"2014","journal-title":"Epigenetics"},{"key":"R23-20260528","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.gastro.2014.04.039","article-title":"Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer","volume":"147","author":"Luo","year":"2014","journal-title":"Gastroenterology"},{"key":"R24-20260528","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1017\/S1462399410001559","article-title":"DNA methylation profiling in cancer","volume":"12","author":"Kondo","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"R25-20260528","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41588-018-0286-6","article-title":"Discovery of common and rare genetic risk variants for colorectal cancer","volume":"51","author":"Huyghe","year":"2019","journal-title":"Nat Genet"},{"key":"R26-20260528","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/1878-0261.12738","article-title":"Blood-derived DNA methylation predictors of mortality discriminate tumor and healthy tissue in multiple organs","volume":"14","author":"Zhang","year":"2020","journal-title":"Mol Oncol"},{"key":"R27-20260528","doi-asserted-by":"crossref","first-page":"e9061","DOI":"10.1371\/journal.pone.0009061","article-title":"Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions","volume":"5","author":"T\u00e4nzer","year":"2010","journal-title":"PLoS One"},{"key":"R28-20260528","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4103\/jcrt.jcrt_2542_22","article-title":"Differential methylation of DNA promoter sequences in peripheral blood mononuclear cells as promising diagnostic biomarkers for colorectal cancer","volume":"20","author":"Mosallaei","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R29-20260528","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2217\/epi.15.114","article-title":"Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences","volume":"8","author":"Moran","year":"2016","journal-title":"Epigenomics"},{"key":"R30-20260528","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.celrep.2018.05.045","article-title":"Cell-of-origin DNA methylation signatures are maintained during colorectal carcinogenesis","volume":"23","author":"Bormann","year":"2018","journal-title":"Cell Rep"},{"key":"R31-20260528","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aan6826","article-title":"Single-cell epigenomics: Recording the past and predicting the future","volume":"358","author":"Kelsey","year":"2017","journal-title":"Science"},{"key":"R32-20260528","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12876-022-02470-z","article-title":"Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection","volume":"22","author":"Xu","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"R33-20260528","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1046\/j.0007-1323.2001.01863.x","article-title":"Detection and clinical significance of occult tumour cells in colorectal cancer","volume":"88","author":"Tsavellas","year":"2001","journal-title":"Br J Surg"},{"key":"R34-20260528","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1373\/clinchem.2008.121962","article-title":"PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment","volume":"55","author":"Kristensen","year":"2009","journal-title":"Clin Chem"},{"key":"R35-20260528","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/13696998.2021.1922240","article-title":"Real-world cost-effectiveness of stool-based colorectal cancer screening in a medicare population","volume":"24","author":"Fisher","year":"2021","journal-title":"J Med Econ"},{"key":"R36-20260528","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0969141320903756","article-title":"Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults","volume":"28","author":"Weiser","year":"2021","journal-title":"J Med Screen"},{"key":"R37-20260528","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/1055-9965.EPI-19-1598","article-title":"Comparison of tissue-based molecular markers in younger versus older patients with colorectal neoplasia","volume":"29","author":"Limburg","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R38-20260528","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3390\/cancers17060927","article-title":"Liquid biopsies in the early diagnosis, prognosis, and tailored treatment of colorectal cancer","volume":"17","author":"Liatsou","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R39-20260528","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1158\/1940-6207.CAPR-23-0285","article-title":"Next-generation multi-target stool DNA panel accurately detects colorectal cancer and advanced precancerous lesions","volume":"17","author":"Gagrat","year":"2024","journal-title":"Cancer Prev Res (Phila)"},{"key":"R40-20260528","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/gutjnl-2012-304149","article-title":"Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer","volume":"63","author":"Church","year":"2014","journal-title":"Gut"},{"key":"R41-20260528","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10620-025-08860-z","article-title":"Application of the colorectal cancer (CRC) screening guiding principles for non-invasive testing to multi-target stool DNA: A case study","volume":"70","author":"Melson","year":"2025","journal-title":"Dig Dis Sci"},{"key":"R42-20260528","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12029-024-01118-3","article-title":"The utility of multitarget stool DNA testing for colorectal cancer screening after a normal colonoscopy","volume":"56","author":"Rao","year":"2024","journal-title":"J Gastrointest Cancer"},{"key":"R43-20260528","doi-asserted-by":"crossref","first-page":"eabb9601","DOI":"10.1126\/science.abb9601","article-title":"Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention","volume":"369","author":"Lennon","year":"2020","journal-title":"Science"},{"key":"R44-20260528","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.annonc.2020.04.013","article-title":"Comment on 'sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA'by M","volume":"31","author":"Taylor","year":"2020","journal-title":"C. Liu et al. Ann Oncol"},{"key":"R45-20260528","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann Oncol"},{"key":"R46-20260528","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrc.2017.7","article-title":"Liquid biopsies come of age: Towards implementation of circulating tumour DNA","volume":"17","author":"Wan","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"R47-20260528","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease","volume":"9","author":"Moss","year":"2018","journal-title":"Nat Commun"},{"key":"R48-20260528","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"R49-20260528","doi-asserted-by":"crossref","first-page":"155119","DOI":"10.1016\/j.prp.2024.155119","article-title":"Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers: Focus on pathological mechanisms","volume":"254","author":"Jasim","year":"2024","journal-title":"Pathol Res Pract"},{"key":"R50-20260528","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"R51-20260528","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.30244","article-title":"Hepatocellular carcinoma detection by plasma methylated DNA: Discovery, Phase I pilot, and Phase II clinical validation","volume":"69","author":"Kisiel","year":"2019","journal-title":"Hepatology"},{"key":"R52-20260528","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa1301969","article-title":"Long-term colorectal-cancer incidence and mortality after lower endoscopy","volume":"369","author":"Nishihara","year":"2013","journal-title":"N Engl J Med"},{"key":"R53-20260528","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R54-20260528","doi-asserted-by":"crossref","first-page":"g2467","DOI":"10.1136\/bmj.g2467","article-title":"Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: Systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"348","author":"Brenner","year":"2014","journal-title":"BMJ"},{"key":"R55-20260528","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12876-019-1086-x","article-title":"Unique characteristics of CpG Island methylator phenotype (CIMP) in a Chinese population with colorectal cancer","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R56-20260528","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1053\/j.gastro.2008.07.076","article-title":"Genomic and epigenetic instability in colorectal cancer pathogenesis","volume":"135","author":"Grady","year":"2008","journal-title":"Gastroenterology"},{"key":"R57-20260528","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/ng1834","article-title":"CpG Island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer","volume":"38","author":"Weisenberger","year":"2006","journal-title":"Nat Genet"},{"key":"R58-20260528","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/s41467-020-17316-z","article-title":"Non-invasive early detection of cancer four years before conventional diagnosis using a blood test","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"R59-20260528","doi-asserted-by":"crossref","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"R60-20260528","doi-asserted-by":"crossref","first-page":"eaan2415","DOI":"10.1126\/scitranslmed.aan2415","article-title":"Direct detection of early-stage cancers using circulating tumor DNA","volume":"9","author":"Phallen","year":"2017","journal-title":"Sci Transl Med"},{"key":"R61-20260528","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"R62-20260528","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/annonc\/mdy119","article-title":"Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification","volume":"29","author":"Liu","year":"2018","journal-title":"Ann Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_938_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:39:22Z","timestamp":1787845162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_938_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_938_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-05-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}